Stock Movers

iHeartPodcasts
Stock Movers
Nieuwste aflevering

1602 afleveringen

  • Stock Movers

    Closing Bell: USA Rare Earth Rallies, CoreWeave Rises, Trade Desk Slips

    26-1-2026 | 5 Min.
    On this episode of Stock Movers:

    Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.

    - USA Rare Earth (USAR) signed a non-binding agreement with the Commerce Department for $1.6 billion in funding, the latest White House deal to boost production of rare-earth elements on domestic soil. The pact — which comes alongside $1.5 billion in private-sector investment — will support the company’s spending on rare-earths mining, processing, metal-making and magnet manufacturing, the Oklahoma-based company said in a statement. USA Rare Earth is one of several companies pursuing what would be the first new US rare-earths mines in decades, if they’re completed. Shares of USA Rare Earth rose as much as 29% on Monday.

    - CoreWeave (CRWV) traded higher today after Nvidia (NVDA), the dominant maker of artificial intelligence chips, invested an additional $2 billion in the cloud computing firm. Nvidia purchased CoreWeave Class A common stock at $87.20 a share, the companies said Monday, in a move aimed at speeding up an effort to add more than 5 gigawatts of AI computing capacity by 2030. As part of the collaboration, CoreWeave will be among the first to deploy forthcoming Nvidia products, including storage systems and a new central processing unit, or CPU. Nvidia, already a CoreWeave investor, previously agreed to buy more than $6 billion in services from the firm through 2032. CoreWeave shares rose as much as 17% in trading Monday, while Nvidia’s stock inched up by less than 1%.
    - Trade Desk (TTD) fell after the advertising technology company said the employment of Chief Financial Officer Alex Kayyal was terminated over the weekend.
    See omnystudio.com/listener for privacy information.
  • Stock Movers

    Coreweave Rises, USA Rare Earth Gains, AppLovin Up After Needham Upgrade

    26-1-2026 | 3 Min.
    On this episode of Stock Movers:
    - Coreweave (CRWV) shares rise after Nvidia, the dominant maker of artificial intelligence chips, invested an additional $2 billion in the cloud computing firm, marking the latest example of the circular financing deals that have lifted valuations of AI companies and fueled concerns about a bubble.
    - USA Rare Earth (USAR) shares gain after it entered into a non-binding letter of intent with the US Department of Commerce for $1.6 billion in funding in exchange for 16.1 million shares issued to the department as well as warrants. USA Rare Earth also raised $1.5 billion in private investment to accelerate domestic heavy rare-earth production.
    - AppLovin (APP) shares up after Needham upgraded the mobile-app marketing company to buy from hold. Analyst Bernie McTernan has “more confidence in the trajectory of e-commerce revenue growth in ‘26E coming at the same time the stock has pulled back off the highs a month ago”
    See omnystudio.com/listener for privacy information.
  • Stock Movers

    CVC Drops, Mankind Rises, Revolution Medicines Drops on Merck News

    26-1-2026 | 2 Min.
    On this episode of Stock Movers:
    - CVC (CVC) shares drop after the company agreed to buy Marathon Asset Management in a cash and equity transaction with a base consideration valued at as much as $1.2 billion.
    - Mankind (MNKD) shares rise after the FDA approved an update to the company’s inhaled insulin, revising recommendations for the starting mealtime dosage.
    - Revolution Medicines (RVMD) shares drop on news Merck is no longer in talks to acquire biotech firm.
    See omnystudio.com/listener for privacy information.
  • Stock Movers

    Merck Ends Talks to Buy Revolution Medicines; USA Rare Earth Surges; Nvidia Invests an Additional $2 Billion in CoreWeave

    26-1-2026 | 3 Min.
    On this episode of Stock Movers:
    - Merck (MRK) is no longer in talks to acquire biotech firm Revolution Medicines (RVMD) after the two companies couldn’t agree on a price, the Wall Street Journal reported, citing people familiar with the matter.A deal could have valued Revolution Medicines at around $30 billion, the report said, adding that talks could restart or another suitor could emerge. Merck is seeking deals that will strengthen its treatments portfolio to counter patent losses that will erode sales by $18 billion over the next five years.
    - USA Rare Earth (USAR) shares rise after it entered into a non-binding letter of intent with the US Department of Commerce for $1.6 billion in funding in exchange for 16.1 million shares issued to the department as well as warrants. US Rare Earth also raised $1.5 billion in private investment to accelerate domestic heavy rare-earth production.
    - Nvidia (NVDA) the dominant maker of artificial intelligence chips, invested an additional $2 billion in CoreWeave (CRWV) to help speed up an effort to add more than 5 gigawatts of AI computing capacity by 2030. Nvidia purchased CoreWeave Class A common stock at $87.20 a share, the companies said Monday. As part of the collaboration, CoreWeave will be among the first to deploy forthcoming Nvidia products, including storage systems and a new central processing unit, or CPU. Nvidia, already a CoreWeave investor, previously agreed to buy more than $6 billion in services from the firm through 2032.
    See omnystudio.com/listener for privacy information.
  • Stock Movers

    Silver Miners Soar; USA Rare Earth Jumps; Revolution Medicines Slide

    26-1-2026 | 3 Min.
    On this episode of Stock Movers:
    - Silver miners, like Hecla (HL) are set to continue outperforming the metal in 2026 as operating leverage, earnings momentum and investor preference for equities amplify gains from elevated prices.
    - USA Rare Earth (USAR) shares soar as much as 62% in premarket trading after the Financial Times reported that the Trump administration is planning to invest $1.6 billion into the mining company.
    - Revolution Medicines (RVMD) shares slide as much as 20% in premarket trading after the Wall Street Journal reported that Merck ended talks to acquire the biotech firm, citing people familiar with the matter.
    See omnystudio.com/listener for privacy information.

Meer Zaken en persoonlijke financiën podcasts

Over Stock Movers

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.
Podcast website

Luister naar Stock Movers, Het Beurscafé en vele andere podcasts van over de hele wereld met de radio.net-app

Ontvang de gratis radio.net app

  • Zenders en podcasts om te bookmarken
  • Streamen via Wi-Fi of Bluetooth
  • Ondersteunt Carplay & Android Auto
  • Veel andere app-functies

Stock Movers: Podcasts in familie

Social
v8.3.1 | © 2007-2026 radio.de GmbH
Generated: 1/26/2026 - 10:57:37 PM